The 2026 Federal Readiness Playbook for ISVs — Chapter 5: Your 90-Day Plan

#federal-market#isv#compliance#fedramp

By — Founder of GovExpress; prior domain experience at Bloomberg Government and GovWin IQ.

From a number to a sequence

The last three chapters built a picture. Chapter 2 turned readiness into a number with six named parts. Chapter 3 opened the most consequential of those parts — compliance — into the verified-versus-self-attested distinction that decides how a claim reads. Chapter 4 set both against the two compliance calendars running through 2026 and left you with one habit: name the clock before you make the claim.

A picture, though, is not a plan. A company can hold an accurate score, a sorted pile of compliance claims, and two calendars in view — and still freeze, because knowing where you stand does not tell you what to do first. This chapter closes that gap. The Prioritized 90-Day Action Plan is the artifact that turns a score into motion: a sequenced set of moves you run in the ninety days ahead of the FedRAMP 20x submission you are aiming at.

The plan is the score, read backward

The 90-day plan is not a generic checklist handed to every company. It is derived from your own score — specifically from the dimensions where you scored thin. A single number tells you whether you are ready; the six dimensions tell you why; the plan takes the “why” and turns it into a sequence. Two companies with the same score get different plans, because the plan targets their weak dimensions, not a template’s.

This is why Chapters 2 through 4 came first. The plan is only as good as the diagnosis under it: you cannot sequence work against a feeling, and you cannot prioritize dimensions you have not measured. The score is the input; the plan is the output; the discipline is to let the diagnosis choose the work rather than doing the parts you already enjoy.

First principle: sequence by leverage, not by comfort

The temptation for a technical founder is to spend the ninety days on the dimension that feels most like home — usually the product, or the security posture that is already strong. That is exactly backward. The plan sequences by leverage: the move that most changes how a federal buyer reads you, done first.

Three ordering rules carry most of the value, and none of them require the score’s internal weighting to apply:

  • Clear the table-stakes gaps before anything else. Registration and visibility is the dimension that gates all the others: a vendor who is not registered, active, and findable in the federal systems buyers check is not evaluated at all — a strong product nobody can see scores as invisible. If this dimension is thin, it comes first, because until it is fixed the rest of the work is unreadable.
  • Convert claims from self-attested to verified where it moves a deal. A compliance posture full of self-attestations is not the same as a verified one (Chapter 3). The highest-leverage compliance work in ninety days is usually not acquiring a new credential — it is making an existing, real one legible and checkable, so a buyer’s due diligence confirms rather than discounts it.
  • Build the thin federal-specific dimensions honestly, not cosmetically. Past performance and federal market-fit evidence are where a first-time seller starts thin by definition (Chapter 2). These move slower than a registration fix, so they get started early even though they finish late — you cannot manufacture a track record in a sprint, but you can begin the moves (teaming conversations, a first small vehicle, documented pilots) whose payoff compounds past day 90.

The through-line: order by how much each move changes the buyer’s read, put the gating dimension first, and start the slow-compounding work early even when its return arrives later.

The three thirty-day moves

A useful way to hold the plan is as three thirty-day segments, each with a center of gravity. This is a framing for sequencing, not a rigid template — your own thin dimensions decide what actually lands in each block.

Days 1–30 — get visible and get honest. Close the table-stakes registration and visibility gaps so you are evaluable at all, and run the Chapter 3 inventory: sort every compliance claim you make into unverified assertion, self-attested, and independently verified. The first month buys you two things that everything later depends on — a vendor a buyer can find, and an honest map of which of your claims will survive scrutiny.

Days 31–60 — convert and build. Take the self-attested claims that matter for the deals you actually want and make them verifiable, so the compliance overlay renders them with provenance a buyer can check. In parallel, begin — not finish — the slow federal-specific work: open the teaming and past- performance conversations, and gather the market-fit evidence that shows real federal demand for your category.

Days 61–90 — assemble the proof and aim it at your submission. Pull the strong dimensions into federal sales assets a buyer can read quickly, and align the whole package to the FedRAMP 20x pipeline for your class. Both pipelines are already open — Class A opened 2026-08-03, Class B and C on 2026-08-31 — so the target is no longer a calendar opening but the date you choose to submit. The goal of the last thirty days is not more work — it is making the work already done legible before that submission.

Sequencing against two calendars

The plan runs against the calendar, not in a vacuum — and, per Chapter 4, there is more than one calendar. For an ISV whose first sale is civilian, the ninety days are sequenced to your FedRAMP 20x submission above; that is the clock this plan answers to.

If defense work is anywhere on your roadmap, the DoW compliance calendar sits alongside it, and the honest posture is the one Chapter 4 named: CMMC Phase I is in force, Phase II is suspended — not cancelled — and DFARS 252.204-7012 remains in force. Treat the Phase II suspension as deferred, not deleted: the plan does not add CMMC certification work to a civilian ninety-day sprint, but it also does not throw away readiness that will serve the defense side when that phase resumes, because much of the underlying control and evidence work carries over.

The seller’s discipline stays what it was: name the clock before you make the claim. The plan is sequenced to one calendar, and it never lets progress on that clock quietly imply progress on the other.

What the plan is not

Two honest limits, because the credibility of the whole exercise depends on them:

  • A completed plan is not a guarantee of an award. It closes the gaps a buyer can see and makes your real strengths legible; it does not buy demand, budget, or a decision that isn’t yours to make. It improves how you read, which is the part inside your control.
  • The plan is a living artifact, not a one-time list. The point of scoring readiness (Chapter 2) is that the number moves as you work. Re-score at the end of the ninety days to see which dimensions actually shifted, and let the new picture write the next plan. A plan you run once and never re-measure is back to working against a feeling.

Note also what the plan deliberately does not expose: it sequences work from the shape of your score — which dimensions are thin and by how much relative to each other — without publishing the internal weighting that produces that shape. You get the prioritized moves; the arithmetic that ranks them stays under the hood. That is by design, and it is the same containment every chapter of this book keeps.

What this chapter hands to the appendix

The plan tells you what to do and in what order. It rests, though, on a quiet claim made all the way back in Chapter 2: that the score under it is computed from observable federal data, with anything you tell us in the intake shown labelled self-reported rather than blended in as fact. A plan derived from a self-graded score would be a plan built on sand.

So the book closes where its credibility comes from. The appendix (Chapter 6) names the six federal data sources behind the readiness picture — at the level of “these are public federal APIs,” no internal mechanics — so that when a buyer, partner, or investor asks “where does this number come from?” the answer is a short, checkable list rather than a shrug. The takeaway to carry into it is the one this chapter is built on: a plan is only as trustworthy as the diagnosis under it, and the diagnosis is only as trustworthy as its sources.

The CMMC brief

What the Phase 2 suspension changed and what it did not — the obligations that still bind, the assessment path a contract puts you on, the scoping decision that drives the cost, and the sequence that fits inside a pipeline. Sourced from the primary record.